STRS Ohio’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.8M | Sell |
28,557
-3,099
| -10% | -$2.11M | 0.07% | 286 |
|
|
2026
Q1 | $24.5M | Sell |
31,656
-1,340
| -4% | -$1.03M | 0.1% | 206 |
|
|
2025
Q4 | $25.5M | Sell |
32,996
-2,589
| -7% | -$1.76M | 0.1% | 213 |
|
|
2025
Q3 | $20M | Sell |
35,585
-865
| -2% | -$489K | 0.07% | 275 |
|
|
2025
Q2 | $19.1M | Buy |
36,450
+2,069
| +6% | +$1.15M | 0.07% | 299 |
|
|
2025
Q1 | $21.8M | Buy |
34,381
+725
| +2% | +$499K | 0.09% | 256 |
|
|
2024
Q4 | $24M | Sell |
33,656
-3,964
| -11% | -$3.33M | 0.1% | 243 |
|
|
2024
Q3 | $39.5M | Sell |
37,620
-200
| -0.5% | -$223K | 0.15% | 157 |
|
|
2024
Q2 | $39.7M | Buy |
37,820
+24
| +0.1% | +$23.3K | 0.16% | 147 |
|
|
2024
Q1 | $36.4M | Buy |
37,796
+3,704
| +11% | +$3.52M | 0.14% | 169 |
|
|
2023
Q4 | $29.9M | Buy |
34,092
+2,837
| +9% | +$2.34M | 0.12% | 193 |
|
|
2023
Q3 | $25.7M | Sell |
31,255
-977
| -3% | -$768K | 0.11% | 214 |
|
|
2023
Q2 | $23.2M | Sell |
32,232
-1,473
| -4% | -$1.14M | 0.1% | 231 |
|
|
2023
Q1 | $27.7M | Sell |
33,705
-333
| -1% | -$251K | 0.12% | 213 |
|
|
2022
Q4 | $24.6M | Sell |
34,038
-809
| -2% | -$597K | 0.11% | 234 |
|
|
2022
Q3 | $24M | Sell |
34,847
-1,163
| -3% | -$732K | 0.11% | 217 |
|
|
2022
Q2 | $21.3M | Sell |
36,010
-4,639
| -11% | -$3.02M | 0.1% | 250 |
|
|
2022
Q1 | $28.4M | Buy |
40,649
+4,439
| +12% | +$2.81M | 0.1% | 232 |
|
|
2021
Q4 | $22.9M | Sell |
36,210
-9,194
| -20% | -$5.65M | 0.08% | 281 |
|
|
2021
Q3 | $27.5M | Sell |
45,404
-3,069
| -6% | -$1.91M | 0.1% | 239 |
|
|
2021
Q2 | $27.1M | Buy |
48,473
+533
| +1% | +$270K | 0.1% | 246 |
|
|
2021
Q1 | $22.7M | Sell |
47,940
-6,894
| -13% | -$3.36M | 0.09% | 267 |
|
|
2020
Q4 | $26.5M | Buy |
54,834
+5,003
| +10% | +$2.7M | 0.1% | 239 |
|
|
2020
Q3 | $27.9M | Sell |
49,831
-2,525
| -5% | -$1.53M | 0.12% | 200 |
|
|
2020
Q2 | $32.7M | Buy |
52,356
+9,434
| +22% | +$5.35M | 0.14% | 171 |
|
|
2020
Q1 | $21M | Buy |
42,922
+1,569
| +4% | +$647K | 0.11% | 210 |
|
|
2019
Q4 | $15.5M | Sell |
41,353
-3,082
| -7% | -$1.04M | 0.07% | 313 |
|
|
2019
Q3 | $12.3M | Sell |
44,435
-1,546
| -3% | -$457K | 0.05% | 336 |
|
|
2019
Q2 | $14.4M | Buy |
45,981
+264
| +0.6% | +$87.9K | 0.06% | 314 |
|
|
2019
Q1 | $18.8M | Buy |
45,717
+893
| +2% | +$368K | 0.09% | 273 |
|
|
2018
Q4 | $16.7M | Buy |
44,824
+1,110
| +3% | +$406K | 0.09% | 279 |
|
|
2018
Q3 | $17.7M | Sell |
43,714
-3,486
| -7% | -$1.33M | 0.08% | 294 |
|
|
2018
Q2 | $16.3M | Sell |
47,200
-1,332
| -3% | -$417K | 0.07% | 303 |
|
|
2018
Q1 | $16.7M | Sell |
48,532
-840
| -2% | -$292K | 0.07% | 294 |
|
|
2017
Q4 | $18.6M | Sell |
49,372
-722
| -1% | -$292K | 0.08% | 284 |
|
|
2017
Q3 | $22.4M | Hold |
50,094
| – | – | 0.1% | 263 |
|
|
2017
Q2 | $24.6M | Sell |
50,094
-1,589
| -3% | -$695K | 0.11% | 247 |
|
|
2017
Q1 | $20M | Sell |
51,683
-8,159
| -14% | -$3.02M | 0.09% | 285 |
|
|
2016
Q4 | $22M | Buy |
59,842
+13,589
| +29% | +$5.17M | 0.1% | 259 |
|
|
2016
Q3 | $18.6M | Sell |
46,253
-1,435
| -3% | -$576K | 0.08% | 291 |
|
|
2016
Q2 | $16.7M | Sell |
47,688
-9,839
| -17% | -$3.79M | 0.07% | 307 |
|
|
2016
Q1 | $20.7M | Sell |
57,527
-9,888
| -15% | -$4.07M | 0.09% | 259 |
|
|
2015
Q4 | $36.6M | Buy |
67,415
+106
| +0.2% | +$57.4K | 0.16% | 170 |
|
|
2015
Q3 | $31.3M | Buy |
67,309
+246
| +0.4% | +$132K | 0.15% | 186 |
|
|
2015
Q2 | $34.2M | Sell |
67,063
-130
| -0.2% | -$63.4K | 0.15% | 195 |
|
|
2015
Q1 | $30.3M | Sell |
67,193
-1,211
| -2% | -$513K | 0.13% | 223 |
|
|
2014
Q4 | $28.1M | Buy |
68,404
+828
| +1% | +$326K | 0.12% | 229 |
|
|
2014
Q3 | $24.4M | Hold |
67,576
| – | – | 0.11% | 252 |
|
|
2014
Q2 | $19.1M | Sell |
67,576
-3,785
| -5% | -$1.12M | 0.09% | 297 |
|
|
2014
Q1 | $21.4M | Sell |
71,361
-1,300
| -2% | -$401K | 0.1% | 264 |
|
|
2013
Q4 | $20M | Buy |
72,661
+2,200
| +3% | +$633K | 0.09% | 277 |
|
|
2013
Q3 | $22M | Buy |
70,461
+10,825
| +18% | +$2.85M | 0.1% | 278 |
|
|
2013
Q2 | $13.4M | Buy |
+59,636
| New | +$13.9M | 0.06% | 369 |
|
Other funds holding REGN
STRS Ohio's REGN Position: Q2 2026 in Review
STRS Ohio reduced its Regeneron Pharmaceuticals (REGN) stake by 9.8% in Q2 2026, selling an estimated $2.11M and leaving 28,557 shares worth $17.8M. The position accounts for 0.07% of the portfolio, ranked #286.
STRS Ohio first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $39.7M in Q2 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- STRS Ohio held 28,557 shares of Regeneron Pharmaceuticals worth $17.8M as of Q2 2026.
- STRS Ohio sold 3,099 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.11M.
- Regeneron Pharmaceuticals made up 0.07% of STRS Ohio's portfolio in Q2 2026, its #286 holding.
- STRS Ohio first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- STRS Ohio's Regeneron Pharmaceuticals position peaked at $39.7M in Q2 2024.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.